JL19001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JL19001, covering 2026-03-19 to 2026-03-19. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I/II Study of JL19001 Injection Alone or in Combination With BCG in Subjects With High Risk Non-Muscle Invasive Bladder Cancer. [Phase 1]